Zusammenfassung
Vigilanz wird üblicherweise als „gerichtete Aufmerksamkeit“, als „Reaktionsbereitschaft“ definiert. „Vigilia“ war die Nachtwache beim römischen Heer, später das Nachtgebet der Kleriker. Head verstand unter Vigilanz einen dynamischen Zustand der neuronalen Massenaktivität, der die Verfügbarkeit und den Organisationsgrad unseres adaptiven Verhaltens determiniert. Für Hansen (1992) stellt Vigilanz eine entscheidende Konstituente des Antriebs dar; Kugler definiert sie als die Bereitschaft des Individuums, auf einen inneren oder äußeren Reiz mit adäquatem Verhalten zu reagieren. Im Englischen hat sich dafür der Begriff „alertness“ durchgesetzt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agnoli A, Manna V, Martucci N (1989) Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Pharmacol Res 9: 277–281
Allain H, Lieury A, Brunet-Bourgin F et al. (1992) Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology 106: S56–S61
Burgess JW (1991) Neurocognition in acute and chronic depression: personality disorder, major depression, and schizophrenia. Biol Psychiatry 30: 305–309
Cassens G, Wolfe L, Zola M (1990) The neuropsychology of depressions. J Neuropsychiatry 2: 202–213
Classen W, Laux G (1989) Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol. Neuropsychobiology 21: 131–140
Classen W, Laux G (1990) Psychometric alterations in treatment with the MAO-A inhibitor moclobemide. J Neural Transm [Suppl] 32: 185–188
Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105: 1–8
Eitan N, Levin Y, Ben-Artzi E, Levy A, Neumann M (1992) Effects of antipsychotic drugs on memory functions of schizophrenic patients. Acta Psychiatr Scand 85: 74–76
Gaebel W, Ulrich G (1987) Visuomotor tracking performance in schizophrenia: relationship with psychopathological subtyping. Neuropsychobiology 17: 66–71
Georgotas A, Reisberg B, Ferris S (1983) First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients. Arch Geront Geriatr 2: 249–254
Georgotas A, McCue RE, Reisberg B et al. (1989) The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatr 1: 135–143
Hansen J (1992) Antrieb und seine Störungen. In: Battegay R, Glatzel J, Pöldinger W, Rauchfleisch U (Hrsg) Handwörterbuch der Psychiatric. Enke, Stuttgart, S 67–72
Hatcher S, Sims R, Thompson D (1990) The effect of chronic lithium treatment on psychomotor performance related to driving. Br J Psychiatry 157: 275–278
Hindmarch I (1986) The effects of psychoactive drugs on car handling and related psychomotor ability: a review. In: O’Hanlon JF, de Gier JJ (eds) Drugs and driving. Taylor & Francis, London, pp 71–82
Hindmarch I, Gudgeon AC (1980) The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 10: 145–150
Hindmarch I, Barwell F, Alford C (1990) Behavioural toxicity of antidepressants. In: Leonhard B, Spencer P (eds) Antidepressants: thirty years on. CNS, London, pp 403–409
Hobi V (1992) Psychopharmaka und Fahrtauglichkeit. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka. Ein Therapie-Handbuch, Bd 1. Springer, Wien, S 217–240
Hoff AL, Shukla S, Helms P et al. (1990) The effects of nortriptyline on cognition in elderly depressed patients. J Clin Psychopharmacol 10: 231–232
Hofferberth B, Fritze J (1984) On the effects of depot neuroleptics on vigilance. A comparison between fluspirilen and a reference compound from the tricyclic range. Med Welt 35: 842–845
Janke W, Debus G, Longo N (1979) Differential psychopharmacology of tranquilizing and sedating drugs. Mod Probl Pharmacopsychiatry 14: 13–98
Johnson LC, Chernik DA (1982) Sedative-hypnotics and human performance. Psychopharmacology 76: 101–113
Judd LL, Ellinwood E, McAdams LA (1990) Cognitive performance and mood in patients with chronic insomnia during 14-days use of flurazepam and midazolam. J Clin Psychopharmacol 10: 56S–67S
King DJ (1990) The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 157: 799–811
Klotz U (1985) Tranquillantien. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Koelega HS (1989) Benzodiazepines and vigilance performance: a review. Psychopharmacology 98: 145–156
Kugler J, Leutner V (Hrsg) (1984) Vigilanz. Ihre Bestimmung und Beeinflussung. Roche, Basel
Moskowitz H, Linnoila M, Roehrs T (1990) Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 10: 44S–55S
Netter P (1988) Individual differences in benzodiazepine-induced changes of memory. In: Hindmarch J, Ott H (eds) Benzodiazepine receptor ligands, memory and information processing. Springer, Berlin Heidelberg New York Tokyo, pp 92–104
Oblowitz H, Robins AH (1983) The effect of clobazam and lorazepam on the psychomotor performance of anxious patients. Br J Clin Pharmacol 16: 95–99
O’Hanlon JF (1991) Review of buspirone’s effect on human performance and related variables. Eur Neuropsychopharmacol 1: 489–501
Ott H (1984) Tages-Hangover bei lang- und kurzwirkenden Benzodiazepinen in verschiedenen psychologischen und physiologischen Testmodellen im Rahmen von Verkehrstauglichkeitsuntersuchungen. In: Kemper FH (Hrsg) Arzneimittel und Verkehrssicherheit. Schering, Berlin, S 112–128
Preskorn SH, Jerkovich GS (1990) Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring. J Clin Psychopharmacol 10: 88–95
Reynolds CF, Perel JM, Kupfer DJ et al. (1987) Open-trial response to antidepressant treatment in elderly patients with mixed depression and cognitive impairment. Psychiatry Res 21: 111–122
Schmidt U, Brendemühl D, Rüther E (1986) Aspects of driving after hypnotic therapy with particular reference to temazepam. Acta Psychiatr Scand [Suppl] 332: 112–118
Seidel WF, Cohen SA, Bliwise NG, Dement WC (1985) Buspirone: an anxiolytic without sedative effect. Psychopharmacology 87: 371–373
Stoudemire A, Hill CD, Morris R et al. (1991) Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly. Am J Psychiatry 148: 1336–1340
Subhan Z (1984) The effects of benzodiazepines on short-term memory and information processing. In: Hindmarch I, Ott H, Roth T (eds) Sleep, benzodiazepines and performance. Springer, Berlin Heidelberg New York, pp 173–181
Tomer R, Flor-Henry P (1989) Neuroleptics reverse attention asymmetries in schizophrenic patients. Biol Psychiatry 25: 852–860
Young RC, Mattis S, Alexopoulos GS et al. (1991) Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. Psychopharmacol Bull 27: 291–299
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Laux, G. (1993). Alltagsrelevante Vigilanzbeeinträchtigung und Psychopharmaka. In: Möller, HJ., Przuntek, H. (eds) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78040-0_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-78040-0_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56399-0
Online ISBN: 978-3-642-78040-0
eBook Packages: Springer Book Archive